Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating rapid PCR-based detection of rifampin and isoniazid resistance in tuberculosis before treatment initiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Tuberculosis | Phase 4 | Status: COMPLETED